Board of Directors and management of Idogen AB to exercise all of their TO 4 warrants and acquire new shares
Idogen’s Board of Directors and management (CEO, CSO and CFO) who hold subscription warrants (TO 4) will all redeem their warrants (TO 4) in full to purchase new shares in the company. The TO 4 subscription warrants are part of the rights issue completed by the company in November 2020 that provides entitlement to acquire shares in Idogen AB for 70% of the volume-weighted price during the period September 6 – 21, 2021. The subscription price for one new share has now been determined at SEK 2.06 per share. The final date for trading with TO 4 is Friday, October 1, though the final date